Evidence map›Paper›PMID 31323867›Full record

ArticleMetabolites2019

Hedvika Primasová, Lydia E H Paul, Gaëlle Diserens, Ester Primasová, Peter Vermathen, Martina Vermathen, Julien Furrer

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Molecules (Basel, Switzerland) · 2021
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hedvika PrimasováDepartment of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Lydia E H PaulDepartment of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
Gaëlle DiserensDepartment of BioMedical Research and Radiology, University of Bern and Inselspital, Erlachstrasse 9a, 3012 Bern, Switzerland.
Ester PrimasováFaculty of Information Technology, Czech Technical University in Prague, Thákurova 9, 16000 Prague, Czech Republic.
Peter VermathenDepartment of BioMedical Research and Radiology, University of Bern and Inselspital, Erlachstrasse 9a, 3012 Bern, Switzerland.
Martina VermathenDepartment of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland. martina.vermathen@dcb.unibe.ch.
Julien FurrerDepartment of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland. julien.furrer@dcb.unibe.ch.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 206021-128736
6 · The paper itself

Abstract

The trithiolato bridged diruthenium complex DiRu-1 [(p-MeC

Indexed as

A2780cis-Pt resistantcytotoxicityHR-MAS NMRmetal-based drugsNMR metabolomicsovarian cancerruthenium complex

Identifiers

PMID31323867
PMCPMC6680816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.